Meet our Team
Oryzon’s management team is composed of passionate biopharma executives exploring new fields of epigenetic science to transform it into innovative personalized medicines for patients.
Management
-
Carlos Buesa
Chief Executive Officer (CEO) -
Jordi Xaus
Chief Scientific Officer (CSO) -
Michael Ropacki
Chief Medical Officer for CNS -
Sonia Gutierrez
Chief of Clinical Operations -
Enric Rello
Chief Operating Officer (COO), Chief Financial Officer (CFO) -
Neus Virgili
Chief Intellectual Property Officer (CIPO) -
Emili Torrell
Chief Business Development Officer (CBDO)
Board Members
-
Carlos Buesa
President (Executive Director) -
Tamara Maes
First Deputy President (Dominical Director) -
Ramón Adell Ramón
Board Member (Independent Director) -
Antonio Fornieles Melero
Board Member (Independent Director) -
Manuel López-Figueroa
Board Member (Independent Director) -
Isabel Aguilera Navarro
Board Member (Independent Director) -
Jose Maria Echarri Torres
Board Member (Dominical Director)
Scientific Advisory Board